Loading
Trials quietly exclude people who do not speak the local language because consent forms and questionnaires exist only in that language. Sponsors should provide validated translations for any language spoken by at least 5 percent of the catchment and fund interpreters; translations of common instruments already exist for dozens of languages.
Protocols may not exclude on language; sponsors provide certified translations of consent and patient-reported outcome instruments in the languages spoken by at least 5 percent of the catchment population (with linguistically validated PRO versions), and fund professional interpreters for visits. Validated translations of common PRO instruments already exist for dozens of languages.
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.